Publication: Serum cytokine profiles in Takayasu's arteritis: search for biomarkers
| dc.contributor.authors | Alibaz-Oner, F.; Yentur, S. P.; Saruhan-Direskeneli, G.; Direskeneli, H. | |
| dc.date.accessioned | 2022-03-13T12:50:39Z | |
| dc.date.accessioned | 2026-01-11T19:01:15Z | |
| dc.date.available | 2022-03-13T12:50:39Z | |
| dc.date.issued | 2015 | |
| dc.description.abstract | Objective. Assessment of disease activity is one of the major difficulties in patients with Takayasu arteritis (TA) during follow-up. To date, no biomarker is universally accepted to be a surrogate for active disease in TA. In this study, we aimed to investigate levels of various pro-and anti-inflammatory, molecules including serum granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin (IL)-6, IL-8, IL-10, IL-18 and IL-23 in patients with TA. Methods. The study included 51 patients (age: 40.6 +/- 12.2 years, F/M: 45/6) with TA and 42 age- and sex-matched healthy controls (age: 38.1 +/- 7.4 years, FIM: 38/4). All patients fulfilled the criteria of the American College of Rheumatology (ACR). TA patients were evaluated by physician's global assessment (PGA; active/inactive) and ITAS2010 (Indian Takayasu Arteritis Clinical Activity Score) in terms of clinical activity in baseline and follow-up visits. Commercial enzyme linked immuno-sorbent assay (ELISA) kits were used for measurements of serum cytokine levels. Results. At baseline, 21(41.2%) patients were active according to PGA and 8 (15.7%) according to ITAS2010. Serum IL-6, IL-8 and IL-18 levels were significantly higher in patients with TA, whereas GM-CSF, IL-10, IL-23 levels were similar to healthy controls. IL-8 significantly decreased in the follow-up, associated with a decrease of clinical activity, whereas IL-23 level significantly increased. When assessed by ITAS2010 active patients had significantly higher IL-18 levels. Conclusion. We found significantly increased IL-6, IL-8 and IL-18 levels in patients with TA compared to healthy controls. Only IL-18 level was significantly higher in active patients assessed by ITAS2010. IL-18 was also the only cytokine in our study that correlated with CRP. These findings suggest that cytokines associated with neutrophilic, pro-inflammatory responses such as IL-6, IL-8 and IL-18 can be potential biomarkers for the assessment of disease activity in TA and warrant further studies in larger series. | |
| dc.identifier.doi | doiWOS:000356402900006 | |
| dc.identifier.eissn | 1593-098X | |
| dc.identifier.issn | 0392-856X | |
| dc.identifier.uri | https://hdl.handle.net/11424/238395 | |
| dc.identifier.wos | WOS:000356402900006 | |
| dc.language.iso | eng | |
| dc.publisher | CLINICAL & EXPER RHEUMATOLOGY | |
| dc.relation.ispartof | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| dc.rights | info:eu-repo/semantics/closedAccess | |
| dc.subject | Takayasu's arteritis | |
| dc.subject | biomarkers | |
| dc.subject | disease activity | |
| dc.subject | GIANT-CELL ARTERITIS | |
| dc.subject | COLONY-STIMULATING FACTORS | |
| dc.subject | DISEASE-ACTIVITY | |
| dc.subject | POLYMYALGIA-RHEUMATICA | |
| dc.subject | AUTOIMMUNITY | |
| dc.subject | LYMPHOCYTES | |
| dc.subject | DIAGNOSIS | |
| dc.subject | INTERLEUKIN-18 | |
| dc.subject | TOCILIZUMAB | |
| dc.subject | VASCULITIS | |
| dc.title | Serum cytokine profiles in Takayasu's arteritis: search for biomarkers | |
| dc.type | article | |
| dspace.entity.type | Publication | |
| oaire.citation.endPage | S35 | |
| oaire.citation.issue | 2 | |
| oaire.citation.startPage | S32 | |
| oaire.citation.title | CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | |
| oaire.citation.volume | 33 |
